Improving access to HIV prevention for women who inject drugs
Implementation of PrEP for Women Who Inject Drugs through Practice Facilitation in Primary and Reproductive Health Care
This study is working to make it easier for women who inject drugs to get PrEP, a medicine that helps prevent HIV, by improving how healthcare clinics provide these services and support.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10844367 on NIH RePORTER |
What this research studies
This research aims to enhance the delivery of pre-exposure prophylaxis (PrEP) to women who inject drugs (WWID) by implementing organizational changes in primary and reproductive healthcare settings. The project focuses on addressing the barriers that prevent WWID from accessing PrEP, which is crucial for preventing HIV infection. By utilizing Practice Facilitation, the research seeks to provide clinics with the necessary support to effectively implement PrEP services, thereby increasing uptake among this vulnerable population. The study will evaluate system-level interventions to ensure that WWID receive the care they need when they seek help for related health issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who inject drugs and are at high risk for HIV infection.
Not a fit: Patients who do not inject drugs or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of HIV among women who inject drugs by improving their access to preventive care.
How similar studies have performed: Previous research has shown that organizational-level interventions can effectively improve healthcare delivery, making this approach promising for addressing the needs of WWID.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Starbird, Laura — University of Pennsylvania
- Study coordinator: Starbird, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.